FMT Protocol

DRUG3 trials

Sponsors

Sheba Medical Center, LanZhou University, Assistance Publique - Hôpitaux de Paris

Conditions

Autism Spectrum DisorderFecal Microbiota Transplantation (FMT)Inflammatory Bowel DiseasesMalignant Melanoma Stage IV

Phase 2

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

RecruitingNCT03166397

Sheba Medical CenterMalignant Melanoma Stage IV

Start: 2017-06-05End: 2026-06-01Target: 30Updated: 2023-01-26

Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms

Not yet recruitingNCT07105267

Assistance Publique - Hôpitaux de ParisAutism Spectrum Disorder, Fecal Microbiota Transplantation (FMT)

Start: 2025-09-01End: 2027-04-01Target: 5Updated: 2025-08-05

Unknown Phase

Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression

Not yet recruitingNCT06471894

LanZhou UniversityInflammatory Bowel Diseases

Start: 2024-07-01End: 2027-12-01Target: 100Updated: 2024-06-25